Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study
详细信息 查看全文
- 作者：Brandon-Luke L. Seagle ; MD ; brandon.seagle@northwestern.edu" class="auth_mail" title="E-mail the corresponding author ; Megan Dayno ; BS ; Anna E. Strohl ; MD ; Stephen Graves ; MS ; Wilberto Nieves-Neira ; MD ; Shohreh Shahabi ; MD
- 关键词：Exenteration ; Uterine neoplasms ; Survival ; Prognosis
- 刊名：Gynecologic Oncology
- 出版年：2016
- 出版时间：December 2016
- 年：2016
- 卷：143
- 期：3
- 页码：472-478
- 全文大小：367 K
文摘
- ass="listitem" id="list_l0005">
- ass="label">•
Overall survival was 63.1 (42.2–107.2) months for node-negative disease.
- ass="label">•
Age, margin status, metastasis, grade, and black race predicted survival.
- ass="label">•
Private insurance and endometrioid histology were associated with longer survival.